Papers by Iliana Michailidou
Page 1 · newest first
- Amyotrophic Lateral Sclerosis: Advances in Diagnosis, Pathophysiology, and Emerging Therapeutic Strategies2025
- The role of complement in the immunopathogenesis of acetylcholine receptor antibody-positive generalized myasthenia gravis: bystander or key player?Frontiers in Immunology · 2025
- The role of amino acid metabolism in neurodegenerative diseasesGene & Protein in Disease · 2024
- Neurological Immune-Related Adverse Events Induced by Immune Checkpoint InhibitorsBiomedicines · 2024
- PMP22 duplication dysregulates lipid homeostasis and plasma membrane organization in developing human Schwann cellsBrain · 2024
- Systemic LPS Administration Stimulates the Activation of Non-Neuronal Cells in an Experimental Model of Spinal Muscular AtrophyCells · 2024
- The Time Trajectory of Choroid Plexus Enlargement in Multiple SclerosisHealthcare · 2024
- Argininemia: Pathophysiology and Novel Methods for Evaluation of the DiseaseApplied Sciences · 2024
- Editorial: Complement in nervous system diseaseFrontiers in Cellular Neuroscience · 2023
- Ldlr-/-.Leiden mice develop neurodegeneration, age-dependent astrogliosis and obesity-induced changes in microglia immunophenotype which are partly reversed by complement component 5 neutralizing antibodyFrontiers in Cellular Neuroscience · 2023
- Defective Schwann cell lipid metabolism alters plasma membrane dynamics in Charcot-Marie-Tooth disease 1A2023
- Sex, aging and immunity in multiple sclerosis and experimental autoimmune encephalomyelitis: An intriguing interactionFrontiers in Neurology · 2023
- The systemic inhibition of the terminal complement system reduces neuroinflammation but does not improve motor function in mouse models of CMT1A with overexpressed PMP22Current Research in Neurobiology · 2023
- Tackling Neuroinflammation After Traumatic Brain Injury: Complement Inhibition as a Therapy for Secondary InjuryNeurotherapeutics · 2022
- Development, Characterization, and in vivo Validation of a Humanized C6 Monoclonal Antibody that Inhibits the Membrane Attack ComplexJournal of Innate Immunity · 2022
- Accumulation of meningeal lymphocytes correlates with white matter lesion activity in progressive multiple sclerosisJCI Insight · 2022
- Accumulation of meningeal lymphocytes, but not myeloid cells, correlates with subpial cortical demyelination and white matter lesion activity in progressive MS patients2021
- Balloon cells promote immune system activation in focal cortical dysplasia type 2bNeuropathology and Applied Neurobiology · 2021
- Meningeal inflammation in multiple sclerosis induces phenotypic changes in cortical microglia that differentially associate with neurodegenerationActa Neuropathologica · 2021
- Systemic inhibition of the membrane attack complex impedes neuroinflammation in chronic relapsing experimental autoimmune encephalomyelitisSHILAP Revista de lepidopterología · 2018
- Complement C3 on microglial clusters in multiple sclerosis occur in chronic but not acute disease: Implication for disease pathogenesisGlia · 2016
- Complement is activated in progressive multiple sclerosis cortical grey matter lesionsJournal of Neuroinflammation · 2016
- Phenotypic Variation in Aicardi–Goutières Syndrome Explained by Cell-Specific IFN-Stimulated Gene Response and Cytokine ReleaseThe Journal of Immunology · 2015
- Complement C1q‐C3–associated synaptic changes in multiple sclerosis hippocampusAnnals of Neurology · 2015
- Activation of endogenous neural stem cells for multiple sclerosis therapyFrontiers in Neuroscience · 2015
- Cellular distribution of glucose and monocarboxylate transporters in human brain white matter and multiple sclerosis lesionsGlia · 2014